Skip to main content
. 2019 Mar 22;13(3):e0007175. doi: 10.1371/journal.pntd.0007175

Table 3. Clinicopathological parameters.

    WEEK 1     WEEK 2     WEEK 3    
PARAMETER   Cy
n = 58
Dim n = 51 Iso n = 53 Cy
n = 54
Dim n = 48 Iso n = 49 Cy
n = 50
Dim n = 44 Iso n = 45
HAEMATOCRIT (%) Horse 20
(19–24)
20
(13–24)
20
(15–23)
22
(20–23)
24
(19–27)
24
(21–27)
22
(18–23)
22
(20–28)
28
(24–28)
  ≤30% 20/21 (95%) 16/16 (100%) 18/18 (100%) 21/21 (100%) 14/15 (93%) 16/17 (94%) 18/18 (100%) 10/11 (91%) 13/15 (87%)
  Donkey 20
(16–24)
20
(16–23)
20
(16–23)
22
(20–26)
23
(21–27)
23
(21–26)
23
(21–25)
26
(23–28)
26
(22–28)
  ≤26% 37/37 (100%) 32/35 (91%) 34/35 (97%) 25/33 (76%) 24/33 (73%) 25/32 (78%) 27/ 32 (84%) 19/33 (58%) 18/30 (60%)
TOTAL
PROTEIN (G/L)
Horse 80
(70–90)
77
(70–87)
88
(76–92)
90
(82–100)
84
(80–93)
96
(88–105)
96
(81–103)
81
(78–93)
100
(93–104)
  Donkey 82
(75–90)
82
(75–90)
80
(75–87)
98
(86–105)
96
(90–105)
98
(90–105)
100 (92–106) 96
(87–106)
95
(90–106)

Haematocrit (%) and total plasma protein (g/l) for the whole treatment population (n = 162) subdivided by trypanocidal drug group (melarsomine dihydrochloride (Cy), diminazene (Dim), isometamidium (Iso) are presented by species (horse and donkey) and time point (week 1, 2 and 3). Parameters are presented as median and IQR and categorised as within or outside the reference range (proportion and percentage).